Work

ประสิทธิภาพของยากลุ่มยากระตุ้นตัวรับเปปไทด์ตัวเหมือนกลูคากอนชนิดที่ 1 ต่อ ดัชนีมวลกายและเส้นรอบเอวในผู้ป่วยโรคอ้วนหรือน้ำหนักตัวเกิน: การทบทวนวรรณกรรมอย่างเป็นระบบและการวิเคราะห์อภิมานเครือข่าย

Year: 2025
Type: article
Abstract: Objective: To evaluate the efficacy of glucagon-like peptide 1 receptor agonists (glucagon-like peptide 1 receptor agonists หรือ GLP-1 receptor agonists) in reducing body mass index (BMI) and waist circumference. Methods: This study was a systematic review and network meta-analysis of randomized controlled trials involving individuals with obesity or overweight, with or without type 2 diabetes, who were treated with GLP-1 receptor agonists. The primary outcomes were BMI and waist circumference. Results: Overall, GLP-1 receptor agonists significantly reduced BMI and waist circumference compared to placebo. Tirzepatide demonstrated the greatest reduction in BMI over 24 to 52 weeks (mean difference [MD] -3.58; 95% Confidence Interval [CI]: -4.68 to -2.47), followed by subcutaneous and oral semaglutide. For treatment durations longer than 52 weeks, oral semaglutide achieved the most substantial BMI reduction (MD -4.70; 95% CI: -6.72 to -2.68). Regarding the reduction of waist circumference, tirzepatide, subcutaneous semaglutide, and oral semaglutide showed the greatest reductions. Subcutaneous semaglutide led to the largest reduction at 12–24 weeks, decreasing waist circumference by 9.3 cm (95% CI: -14.61 to -3.99), while tirzepatide achieved the most significant reduction beyond 24 weeks, with a decrease of 12.74 cm (95% CI: -16.57 to -8.90) for treatment durations exceeding 52 weeks. These findings corresponded with reductions in body weight and BMI. Conclusion: GLP-1 receptor agonists, particularly tirzepatide and semaglutide, are highly effective in reducing BMI and waist circumference in individuals with or without type 2 diabetes. These results offer valuable insights to guide pharmacological treatment choices for weight management.
Language: Thai
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7217705538
FWCI:
Cites: 48
Cited by:
Related to: 10